A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue
Page(s): 510
Download in electronic PDF format for $75
Abstract: A formulation for preparing Imatinib 40-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, imatninib, formulation, hazardous medication, antineoplastic agent, cancer, leukemia, gastrointestinal stromal tumor, GIST, protein tyrosine kinase inhibitor, BCR-ABL inhibitor, receptor tyrosine kinase inhibitor, platelet-derived growth factor receptor, PDGF, PDGFR, stem cell factor inhibitor, SCF, c-kit inhibitor